Nancy oversees the Bioanalytical Development team, which develops assays to evaluate and validate gene editing technology for therapeutics.
Prior to Life Edit, Nancy spent two years at KBI Biopharma.
Nancy received her BS in Psychology from University of Hawaii and her Ph.D. in Biochemistry and Biophysics from University of North Carolina.
.svg)
.svg)
To rewrite the future by curing disease, making any edit, anywhere.
To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.
We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.
